{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:13:40Z","timestamp":1794381220274,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010199"],"award-info":[{"award-number":["2022A1515010199"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A03J0189"],"award-info":[{"award-number":["2024A03J0189"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A06J0188"],"award-info":[{"award-number":["2024A06J0188"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008693","name":"Gulf Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117192","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T03:10:45Z","timestamp":1722654645000},"page":"117192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Targeted co-delivery of rapamycin and oxaliplatin by liposomes suppresses tumor growth and metastasis of colorectal cancer"],"prefix":"10.1016","volume":"178","author":[{"given":"Hang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengke","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117192_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117192_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"12","key":"10.1016\/j.biopha.2024.117192_bib4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2024.117192_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mc.23183","article-title":"Immunogenic cell death in colon cancer prevention and therapy","volume":"59","author":"Ruan","year":"2020","journal-title":"Mol. Carcinog."},{"issue":"30","key":"10.1016\/j.biopha.2024.117192_bib6","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1039\/D1NR03288G","article-title":"Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response","volume":"13","author":"Yu","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.117192_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jconrel.2021.02.032","article-title":"Oxygen and oxaliplatin-loaded nanoparticles combined with photo-sonodynamic inducing enhanced immunogenic cell death in syngeneic mouse models of ovarian cancer","volume":"332","author":"Zheng","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.117192_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2023.04.011","article-title":"Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation","volume":"357","author":"Gu","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.117192_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: At the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2024.117192_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/IJN.S270939","article-title":"Delivery of rapamycin by liposomes synergistically enhances the chemotherapy effect of 5-fluorouracil on colorectal cancer","volume":"16","author":"Chen","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117192_bib12","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.2147\/IJN.S373777","article-title":"Rapamycin liposomes combined with 5-fluorouracil inhibits angiogenesis and tumor growth of APC ((Min\/+)) mice and AOM\/DSS-induced colorectal cancer mice","volume":"17","author":"Liu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117192_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116883","article-title":"Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment","volume":"176","author":"Jia","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.117192_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.989881","article-title":"Biomimetic nanoparticles for tumor immunotherapy","volume":"10","author":"Yu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"26","key":"10.1016\/j.biopha.2024.117192_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine tumor targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv. Mater."},{"issue":"24","key":"10.1016\/j.biopha.2024.117192_bib16","doi-asserted-by":"crossref","first-page":"10906","DOI":"10.1039\/D1NR02018H","article-title":"Tumor microenvironment-triggered in situ cancer vaccines inducing dual immunogenic cell death for elevated antitumor and antimetastatic therapy","volume":"13","author":"Ding","year":"2021","journal-title":"Nanoscale"},{"issue":"15","key":"10.1016\/j.biopha.2024.117192_bib17","article-title":"Recent advances in nanoparticle-based co-delivery systems for cancer therapy","volume":"12","author":"Al","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.biopha.2024.117192_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114445","article-title":"Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment","volume":"188","author":"Gao","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117192_bib19","article-title":"Nanoscale metal-organic framework delivers rapamycin to induce tissue immunogenic cell death and potentiates cancer immunotherapy","volume":"50","author":"Tian","year":"2023","journal-title":"Nanomedicine-Uk"},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40580-022-00343-5","article-title":"Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy","volume":"9","author":"Chen","year":"2022","journal-title":"Nano Converg."},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1080\/10717544.2022.2058647","article-title":"Self-assembling peptides-based nano-cargos for targeted chemotherapy and immunotherapy of tumors: recent developments, challenges, and future perspectives","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117192_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1118546","article-title":"Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer","volume":"11","author":"Deng","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2024.117192_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123316","article-title":"Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulation","volume":"644","author":"Zhu","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2022.100917","article-title":"Folate receptor as a biomarker and therapeutic target in solid tumors","volume":"47","author":"Young","year":"2023","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.biopha.2024.117192_bib25","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/IJN.S398046","article-title":"Resveratrol loaded by folate-modified liposomes inhibits osteosarcoma growth and lung metastasis via regulating JAK2\/STAT3 pathway","volume":"18","author":"Zhu","year":"2023","journal-title":"Int J. Nanomed."},{"issue":"12","key":"10.1016\/j.biopha.2024.117192_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102739","article-title":"An intelligent nanovehicle armed with multifunctional navigation for precise delivery of toll-like receptor 7\/8 agonist and immunogenic cell death amplifiers to eliminate solid tumors and trigger durable antitumor immunity","volume":"11","author":"Hao","year":"2022","journal-title":"Adv. Health Mater."},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-023-02688-z","article-title":"Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery","volume":"42","author":"Long","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12951-023-01916-0","article-title":"Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy","volume":"21","author":"Ma","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"22","key":"10.1016\/j.biopha.2024.117192_bib29","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biopha.2024.117192_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1152934","article-title":"Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: an update review","volume":"14","author":"Zhai","year":"2023","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2093518","article-title":"PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2024.117192_bib32","article-title":"The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"issue":"32","key":"10.1016\/j.biopha.2024.117192_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002160","article-title":"On-demand autophagy cascade amplification nanoparticles precisely enhanced oxaliplatin-induced cancer immunotherapy","volume":"32","author":"Wang","year":"2020","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2024.117192_bib34","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","article-title":"Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2020","journal-title":"Acs Nano"},{"issue":"4","key":"10.1016\/j.biopha.2024.117192_bib35","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/acsnano.0c01676","article-title":"Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis","volume":"14","author":"Guo","year":"2020","journal-title":"Acs Nano"},{"issue":"1","key":"10.1016\/j.biopha.2024.117192_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-020-01297-0","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.117192_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1040256","article-title":"Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer","volume":"13","author":"Fang","year":"2022","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117192_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2024.117192_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154-155","author":"Bottger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:32:40Z","timestamp":1777861960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222401076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":39,"alternative-id":["S075333222401076X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117192","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted co-delivery of rapamycin and oxaliplatin by liposomes suppresses tumor growth and metastasis of colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117192"}}